Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Therapy”

2,498 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,498 results

Testing effectiveness (Phase 2)Looking for participantsNCT05983107
What this trial is testing

Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer

Who this might be right for
HR+/HER2- Advanced Breast CancerTargeted Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102
Testing effectiveness (Phase 2)Study completedNCT01592500
What this trial is testing

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Who this might be right for
Pediatric Growth Hormone Deficiency
OPKO Health, Inc. 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT05262400
What this trial is testing

Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Who this might be right for
Breast CancerSolid Tumors
Pfizer 235
Testing effectiveness (Phase 2)Study completedNCT01110707
What this trial is testing

A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve

Who this might be right for
InfertilityOvulation Induction
Merck KGaA, Darmstadt, Germany 131
Large-scale testing (Phase 3)Ended earlyNCT00066807
What this trial is testing

Premenopausal Endocrine Responsive Chemotherapy Trial

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 29
Testing effectiveness (Phase 2)Study completedNCT03346967
What this trial is testing

Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency

Who this might be right for
Hormone Deficiency
Vinmec Research Institute of Stem Cell and Gene Technology 30
Large-scale testing (Phase 3)Ended earlyNCT02532400
What this trial is testing

Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Ruijin Hospital 21
Not applicableActive Not RecruitingNCT05874726
What this trial is testing

Biological Sample Repository for Gastrointestinal Disorders

Who this might be right for
ObesityObesity, MorbidObesity, Primary+14 more
Pichamol Jirapinyo, MD, MPH 500
Large-scale testing (Phase 3)Study completedNCT06774885
What this trial is testing

Role of Folic Acid in the Management of Adjuvant Endocrine Therapy-Induced Hot Flashes in Breast Cancer Patients

Who this might be right for
THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS
Future University in Egypt 120
Testing effectiveness (Phase 2)Ended earlyNCT00138125
What this trial is testing

Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Translational Oncology Research International 2
Not applicableStudy completedNCT02791750
What this trial is testing

5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma

Who this might be right for
Breast Cancer
Institut de Cancérologie de Lorraine 150
Not applicableStudy completedNCT06830525
What this trial is testing

Development of a Personalized Growth Hormone Treatment Profile (PGTP) Report for Pediatric Endocrinology

Who this might be right for
Growth Hormone Deficiency (GHD)
Luis Fernandez Luque 40
Testing effectiveness (Phase 2)Study completedNCT01204190
What this trial is testing

Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.

Who this might be right for
Contraception
Bayer 173
Post-approval studies (Phase 4)Ended earlyNCT05205837
What this trial is testing

A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial

Who this might be right for
HypogonadismHypogonadism, MaleHypogonadotropic Hypogonadism
Rigshospitalet, Denmark 8
Testing effectiveness (Phase 2)Looking for participantsNCT05355272
What this trial is testing

Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)

Who this might be right for
Gulf War SyndromeAdult Growth Hormone Deficiency
Baylor College of Medicine 20
Not applicableStudy completedNCT01897753
What this trial is testing

Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age

Who this might be right for
Small For Gestational Age (SGA)
Pfizer 264
Testing effectiveness (Phase 2)UnknownNCT06470672
What this trial is testing

Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer

Who this might be right for
Advanced Breast CancerHormone-receptor-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
Fudan University 32
Large-scale testing (Phase 3)Looking for participantsNCT05891093
What this trial is testing

Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)

Who this might be right for
Breast Cancer
Fudan University 766
Not applicableLooking for participantsNCT05442463
What this trial is testing

Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans

Who this might be right for
Hormone Therapy
University of Calgary 200
Large-scale testing (Phase 3)Active Not RecruitingNCT02246621
What this trial is testing

Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 493
Next Page